Start your weight loss journey today

The safety and effectiveness of Compounded Semaglutide have been studied in four 68-week trials. Three were randomized, double-blind, placebo-controlled (including 16-week dose escalation) and one was a randomized, double-blind, placebo-controlled withdrawal study in which patients receiving Compounded Semaglutide continued treatment or switched to placebo. In the four studies, more than 2,600 patients received Compounded Semaglutide for up to 68 weeks and more than 1,500 patients received a placebo. Compounded Semaglutide trial results showed overweight or obese adults receiving weekly semaglutide had a medium weight loss of 14.9% at 68 weeks. In this same study, nearly 70% of participants were able to achieve a 10% weight loss threshold by taking semaglutide. And 32% of participants lost at least 20% of their initial weight. Compounded Tirzepatide has also been extensively studied and is FDA approved for weight loss in a supervised program. 

· Real Weight Loss results of up to 4 pounds per week

· Powerful appetite suppressant

· Improves Insulin resistance, Burns Fat and Boosts Energy

· Safe & Effective Once Weekly Injection

· Use in combination with dietary modification and exercise for a High Success Rate

· FDA Approved for Weight Loss

The most commonly reported side effect is weight loss. However, some have reported nausea, vomiting, diarrhea, stomach pain, or constipation. The rarest risks of serious effects increases in patients with hypoglycemia, kidney problems, and risk of allergic reactions. This medication is ideal for those who are in good health with no kidney or liver issues who wish to lose weight. The medication is not insulin and should not be used if you have type 1 diabetes or develop diabetic ketoacidosis.